Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 646, Issue 1-2, 2008, Pages 17-24

  Chan, Wan ^a   Yue, Hao ^a   Poon, Wing Tat ^b   Chan, Yan Wo ^b   Schmitz, Oliver J ^c   Kwong, Daniel W J ^a   Wong, Ricky N S ^a   Cai, Zongwei ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b PRINCESS MARGARET HOSPITAL   (Hong Kong)

^c UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

Aristolochic acid; Aristolochic acid nephropathy; DNA adducts; LC MS

Indexed keywords

7 (DEOXYADENOSIN N 6 YL)ARISTOLACTAM 2; ARISTOLOCHIC ACID; ARISTOLOLACTAM; DEOXYADENOSINE; DEOXYCYTIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; ELECTROSPRAY MASS SPECTROMETRY; KIDNEY; LIQUID CHROMATOGRAPHY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; ARISTOLOCHIC ACIDS; CHROMATOGRAPHY, LIQUID; DNA ADDUCTS; KIDNEY; LIVER; MALE; MOLECULAR STRUCTURE; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ARISTOLOCHIA; ASARUM; RATTUS;

EID: 54149083563     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.08.012     Document Type: Article

References (44)

1. Zhou X.G., Zheng C.Y., Sun J.Y., and You T.Y. Analysis of nephroloxic and carcinogenic aristolochic acids in Aristolochia plants by capillary electrophoresis with electrochemical detection at a carbon fiber microdisk electrode. J. Chromatogr. A 1109 (2006) 152-159
2. Li W., Gong S.X., Wen D.W., Che B.Q., Liao Y.P., Liu H.W., Feng X.F., and Hu S.L. Rapid determination of aristolochic acid I and II in Aristolochia plants from different regions by beta-cyclodextrin-modified capillary zone electrophoresis. J. Chromatogr. A 1049 (2004) 211-217
3. Chan W., Lee K.-C., Liu N., and Cai Z.W. A sensitivity enhanced high-performance liquid chromatograph fluorescence method for the detection of nephrotoxic and carcinogenic aristolochic acid in herbal medicines. J. Chromatogr. A 1164 (2007) 113-119
4. Debelle F.D., Nortier J.L., De Prez E.G., Garbar C.H., Vienne A.R., Salmon I.J., Deschodt-Lanckman M.M., and Vanherweghem J.L. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J. Am. Soc. Nephrol. 13 (2002) 431-436
5. Vanherweghem J.-L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., Vanhaelenfastre R., and Vanhaelen M. Rapirly progressive interstitial renal fibrosis in young-women-associated with slimming regimen including Chinese herbs. Lancet 341 (1993) 387-391
6. Gold L.S., and Zeiger E. Handbook of Carcinogenic Potency and Genotoxicity Databases (1997), CRC Press, Boca Raton, FL
7. Kupchan M.S., and Doskotch R.W. Tumor inhibitors. Part I. Aristolochic acid, the active principle of Aristolochia indica. J. Med. Pharm. Chem. 5 (1962) 657-659
8. Rucker G., and Chung B.S. Aristolochic acids from Aristolochia manshuriensis. Plant Med. 27 (1975) 68-71
9. Mengs U., Lang W., and Poch J.A. The carcinogenic action of aristolochic acid in rats. Arch. Toxicol. 51 (1982) 107-119
10. Debelle F.D., Vanherweghem J.L., and Nortier J.L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 74 (2008) 158-169
11. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 18 (1997) 1063-1067
12. Nortier J.L., Martinez M.C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein M., Depierreux M.F., De Pauw L., Abramowicz D., Vereerstraeten P., and Vanherweghem J.L. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 342 (2000) 1686-1692
13. Arlt V.M., Stiborova M., and Schmeiser H.H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17 (2002) 265-277
14. Gold L.S., and Stone T.H. Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert. N. Engl. J. Med. 349 (2003) 1576-1577
15. Laing C., Hamour S., Sheaff M., Miller R., and Woolfson R. Chinese herbal uropathy and nephropathy. Lancet 368 (2006) 338-1338
16. Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Femandes A., Rosenquist T., Medverec Z., Jakovinal K., Brdar B., Slade N., Turesky R.J., Goodenough A.K., Rieger R., Vukelic M., and Jelakovic B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 12129-12134
17. Arlt V.M., Stiborova M., vom Brocke J., Simoes M.L., Lord G.M., Nortier J.L., Hollstein M., Philips D.H., and Schmeiser H.H. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 25 (2007) 2253-2261
18. Arlt V.M., Ferluga D., Stiborova M., Pfohl-Leszkowicz A., Vukelic M., Ceovic S., Schmeiser H.H., and Cosyns J.-P. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?. Int. J. Cancer 101 (2002) 500-502
19. 32P-postlabelling analysis of the DNA adducts form by aristolochic acid I and II. Carcinogenesis 11 (1990) 1627-1633
20. Stiborova M., Frei E., Wiessler M., and Schmeiser H.H. Human cytochrome P450 enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for the reductive activation by CYP1A1 and CYP1A2. Chem. Res. Toxicol. 14 (2001) 1128-1137
21. Stiborova M., Frei E., Breuer A., Wiessler M., and Schmeiser H.H. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase-P-32-postlabeling analysis of DNA adduct formation. Mutat. Res. 493 (2001) 149-160
22. Stiborova M., Frei E., Sopko B., Sopkova K., Markova V., Lankova M., Kumstyrova T., Wiessler M., and Schmeiser H.H. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H: quinone oxidoreductase. Carcinogenesis 24 (2003) 1695-1703
23. Schmeiser H.H., Frei E., Wiessler M., and Stiborova M. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by P-32-post-labelling: evidence for reductive activation by peroxidases. Carcinogenesis 18 (1997) 1055-1062
24. Schmeiser H.H., Schoepe K.B., and Wiessler M. DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis 9 (1988) 297-303
25. Arlt V.M., Pfohl-Loszkowicz A., Cosyns J.-P., and Schmeiser H.H. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat. Res. 494 (2001) 143-150
26. Mei N., Arlt V.M., Philips D.H., Heflich R.H., and Chen T. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mutat. Res. 602 (2006) 83-91
27. Dong H., Suzuki N., Torres M.C., Bonala R.R., Johnson F., Grollman A.P., and Shibutani S. Quantitative determination of aristolochic acids-derived DNA adducts in rats using 32-P-postlabeling/polyacrylamide gel electrophoresis analysis. Drug Metab. Dispos. 34 (2006) 1122-1127
28. Doerge D.R., Chirchwell M.I., Marques M.M., and Beland F.A. Quantitative analysis of 4-aminobiphenyl-C8-deoxyguanosyl DNA adducts produced in vitro and in vivo using HPLC-ES-MS. Carcinogenesis 20 (1999) 1055-1061
29. Chan W., Zheng Y.F., and Cai Z.W. Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids. J. Am. Soc. Mass Spectrom. 18 (2007) 642-650
30. Soglia J.R., Turesky R.J., Paehler A., and Vouros P. Quantification of the heterocyclic aromatic amine DNA adduct N-(deoxyguanosin-8-yl)-2-amino-3-methylimidazo[4,5-f]quinoline in livers of rats using capillary liquid chromatography/microelectrospray mass spectrometry: a dose-response study. Anal. Chem. 73 (2001) 2819-2827
31. Paehler A., Richoz J., Soglia J., Vourous P., and Turesky R.J. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry. Chem. Res. Toxicol. 15 (2002) 551-561
32. Singh R., and Farmer P.B. Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection. Carcinogenesis 27 (2005) 178-196
33. Pfau W., Schmeiser H.H., and Wiessler M. Aristolochic acid binds covalently to exocyclic amino group of purine nucleotides in DNA. Carcinogenesis 11 (1990) 313-319
34. 6-adenylarylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen. Chem. Res. Toxicol. 4 (1991) 581-586
35. Arlt V.M., Wiessler M., and Schmeiser H.H. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene. Carcinogenesis 21 (2000) 235-242
36. Arlt V.M., Schmeiser H.H., and Pfeifer G.P. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR. Carcinogenesis 22 (2001) 133-140
37. Green-Church K.B., and Limbach P.A. Mononucleotide gas-phase proton affinities as determined by kinetic method. J. Am. Soc. Mass Spectrom. 11 (2000) 24-32
38. 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I. IARC Sci. Publ. 124 (1993) 167-171
39. Stiborova M., Frei E., Sopko B., Wiessler M., and Schmeiser H.H. Carcinogenic aristolochic acids upon activation by DT-diaphorase from adducts found in DNA of patients with Chinese herbs nephropathy. Carcinogenesis 23 (2002) 617-625
40. Stiborova M., Frei E., Sopko B., Wiessler M., and Schmeiser H.H. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts in patients with urothelial cancer. Int. J. Cancer 113 (2005) 189-197
41. Blake R.D. Informational Biopolymers of Genes and Gene Expression (2005), University Science Books, California 288
42. Cosyns J.-P., Dehoux J.-P., Guiot Y., Geobbels R.-M., Robert A., Bernard A.M., and de Strihou C.Y. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy. Kidney Int. 59 (2001) 2164-2173
43. Mengs U. Acute toxicity of aristolochic acid in rodents. Arch. Toxicol. 59 (1987) 328-331
44. Singh R., Gaskell M., Le Pla R.C., Kaur B., Azim-Araghi A., Roach J., Koukouves G., Souliotis V.L., Kyrtopoulos S.A., and Farmer P.B. Detection and quantitation of benzo[a]pyrene-derived DNA adducts in mouse liver by liquid chromatography-tandem mass spectrometry: comparison with 32P-postlabeling. Chem. Res. Toxicol. 19 (2006) 868-878